GCPAX | JHQCX | GCPAX / JHQCX | |
Total Expense Ratio | 0.93 | 1.33 | 70% |
Annual Report Gross Expense Ratio | 1.07 | 1.33 | 80% |
Fund Existence | 11 years | 12 years | - |
Gain YTD | -0.508 | -1.038 | 49% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 260M | 20.9B | 1% |
Annual Yield % from dividends | 0.46 | 0.09 | 518% |
Returns for 1 year | 6.57 | 5.84 | 112% |
Returns for 3 years | 41.80 | 36.87 | 113% |
Returns for 5 years | 68.21 | 51.76 | 132% |
Returns for 10 years | 97.06 | 99.23 | 98% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIJYX | 29.22 | -0.19 | -0.65% |
Fidelity Advisor Biotechnology Z | |||
MSBQX | 11.94 | -0.15 | -1.24% |
Morgan Stanley American Resilience R6 | |||
NCIGX | 30.98 | -0.41 | -1.31% |
Nuveen International Value C | |||
MNHWX | 26.13 | -0.41 | -1.54% |
Manning & Napier Pro-Blend Max Term W | |||
RSIPX | 14.62 | -0.23 | -1.55% |
Columbia Disciplined Core Inst2 |